CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2017, Vol. 35 ›› Issue (1): 89-93.
• REVIEWS • Previous Articles Next Articles
Yong-hua ZHOU*(), Ying-ying YANG, Xiao-lin FAN, Xue SAI
Received:
2016-04-14
Online:
2017-02-28
Published:
2017-03-06
Contact:
Yong-hua ZHOU
E-mail:Toxo2001@163.com
Supported by:
[1] | 王勇. 后血吸虫病传播阻断阶段: 肝纤维化问题[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 404-406. |
[2] | Xu J, Liu X, Koyama Y, et al. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies[J]. Front Pharmacol, 2014, 5(1): 167. |
[3] | Chuah C, Jones MK, Burke ML, et al. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology[J]. Trends Parasitol, 2014, 30(3): 141-150. |
[4] | 陈艳, 肖政. 白藜芦醇及其伍用吡喹酮对小鼠日本血吸虫肝纤维化的治疗作用[J]. 中国寄生虫学与寄生虫病杂志, 2013, 31(5): 337-341. |
[5] | Noack M, Miossec P.Th17 and regulatory T cell balance in autoimmune and inflammatory diseases[J]. Autoimmun Rev, 2014, 13(6): 668-677. |
[6] | 郑钰涵, 吴晓东, 孙兵. Th17细胞分化和功能的研究进展[J]. 生命科学, 2012, 22(6): 535-537. |
[7] | Littman DR, Rudensky AY.Th17 and regulatory T cell in mediating and restraining inflammation[J]. Cell, 2010, 140(6): 845-858. |
[8] | Ye Y, Xie X, Yu J, et al. Involvement of Th17 and Th1 effector responses in patients with hepatitis B[J]. J Clin Immunol, 2010, 30(4): 546-555. |
[9] | KornT, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells[J].Annu Rev Immunol, 2009, 27(1): 485-517. |
[10] | Giles DA, Moreno-Fernandez ME, Divanovic S.IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression[J]. Curr Drug Targets, 2015, 16(12): 1315-1323. |
[11] | Zhang JY, Zou ZS, Huang A, et al. Hyper-activated pro-inflammatory CD16+ monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B[J]. PLoS One, 2011, 6(3): e17484. |
[12] | 吕勤, 杨小猛, 肖小军, 等. Th17细胞及其细胞因子白细胞介素-17在粉尘螨致敏哮喘小鼠中的变化[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(2): 127-129. |
[13] | 管海涛, 赵金丽, 冯瑞, 等. 白细胞介素17促进肝纤维化发生发展的机制[J]. 临床肝胆病杂志, 2013, 29(5): 370-374. |
[14] | Tank Z, Qian X, Jiang R, et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation[J]. J Immunol, 2013, 191(14): 1835-1849. |
[15] | Yasumi Y, Takikawa Y, Endo R, et al. Interleukin-17 as a new marker of severity of acute hepatic injury[J]. Hepatol Res, 2007, 37(4): 248-254. |
[16] | Feng W, Li W, Liu W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in is oproterenol-induced heart failure[J]. Exp Mol Pathol, 2009, 87(3): 212-218. |
[17] | Simonian PL, Roark CL, Wehrmann F, et al. TH17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis[J]. J Immunol, 2009, 182(1): 657-665. |
[18] | Strober W, Kitani A, Fichtner-Feigl S, et al. The signaling function of the IL-13 relpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance[J]. Curr Mol Med, 2009, 9(6): 740-750. |
[19] | Liu T, Dai W, Li C, et al. Baicalin alleviates silica-induced lung inflammation and fibrosis by inhibiting the Th17 response in C57BL/6 mice[J]. J Nat Prod, 2015, 78(12): 3049-3057. |
[20] | Smith PM, Shainheit MG, Bazzone LE, et al. Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis[J]. J Immunol, 2009, 183(5): 3317-3323. |
[21] | 谷玉清, 张玉侠, 黄大可, 等. Thl7细胞因子及炎症趋化因子在日本血吸虫感染小鼠肝脏中的表达[J]. 安徽医科大学学报, 2011, 46(11): 1124-2229. |
[22] | 徐蕾. IL-17在日本血吸虫肝纤维化的表达研究[D]. 武汉: 华中科技大学, 2012. |
[23] | 陈殿慧. 日本血吸虫感染C57BL/6小鼠肝脏和肺脏中IL-17的特点[D]. 广州: 广州医科大学, 2014. |
[24] | Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cell exacerbates liver fibrosis in mice[J]. Gastroenterology, 2012, 143(3): 765-776. |
[25] | Sun HQ, Zhang JY, Zhang H, et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis[J]. J Viral Hepat, 2012, 19(6): 396-403. |
[26] | Kong X, Feng D, Wang H, et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice[J]. Hepatology, 2012, 56(3): 1150-1159. |
[27] | 徐天华, 陈金铃, 朱丹丹, 等. 肝星状细胞在逆转肝纤维化中的作用[J]. 中国人兽共患病学报, 2015, 31(11): 1065-1068. |
[28] | 赛雪, 何兴, 潘卫庆. 肝星状细胞与血吸虫病肝纤维化[J]. 国际医学寄生虫病杂志, 2013, 4(3): 159-161. |
[29] | 赵雷, 杨东亮. 血吸虫病肝纤维化发病机制[J]. 临床肝胆病杂志, 2015, 31(3): 342-344. |
[30] | 李兰, 孙颖, 王洪武, 等. 血吸虫病肝纤化小鼠IL-22表达及肝星状细胞衰老的意义[J]. 中国血吸虫病防治杂志, 2014, 26(2): 169-174. |
[31] | 许云飞, 杨文涛, 王春凤, 等. CD4+CD25+调节性T细胞在蠕虫感染免疫中的作用[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(2): 148-151. |
[32] | 黄俊, 高志岩, 黎小妍, 等. 日本血吸虫感染小鼠肠系膜淋巴结T细胞亚群的变化[J]. 中国免疫学杂志, 2011, 27(2): 103-106. |
[33] | Kandulski A, Wex T, Kuester D, et al. Naturally occurring regulatory T cells(CD4+, CD25 high, FOXP3+)in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-betal[J]. Helicobacter, 2008, 13(4): 295-303. |
[34] | Claassen MA, DeKnegt RJ, Tilanus HW, et al. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J]. J Hepatol, 2010, 52(3): 315-321. |
[35] | Li J, Qiu SJ, She WM, et al. Significance of the balance between regulatory T(Treg) and T helper 17(Th17)cells during hepatitis B virus related liver fibrosis[J]. PLoS One, 2012, 7(6): e39307. |
[36] | Gu L, Deng WS, Sun XF, et al. Repamycin ameliorates CCL4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance[J]. Mol Med Rep, 2016, 14: 1153-1161. |
[37] | 王十锦, 张蓓, 王丽, 等. 大鼠肝损伤模型中Th17/Treg失衡的研究[J]. 免疫学杂志, 2014, 30(2): 133-138. |
[38] | 苏智军, 余雪平, 郭如意, 等. 慢性乙型肝炎患者外周血调节性T淋巴细胞/Th17细胞及其相关细胞因子的检测及其意义[J]. 中华传染病杂志, 2012, 30(11): 686-690. |
[39] | 陈光, 刘蕾, 毕胜, 等. 约氏疟原虫感染早期小鼠Treg/Th17比值的初步研究[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(6): 425-429. |
[40] | 罗雪平, 陈殿慧, 谢红艳, 等. 日本血吸虫感染小鼠肠系膜淋巴结Th17细胞的免疫应答[J]. 中国寄生虫学与寄生虫病杂志, 2012, 30(4): 258-261. |
[1] | LI Jie, WEN Yusong, LI Zhaojun. Effect of tourism development on schistosomiasis control in China [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(3): 355-360. |
[2] | CHEN Lin, ZHU Jifeng, QIU Jingfan, XU Zhipeng, ZHANG Donghui, CHEN Lu, HE Jian, LI Wei, YANG Kun, JI Minjun. Design and development of a virtual simulation project for schistosomiasis control based on the One Health concept [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(1): 81-84. |
[3] | JIANG Xiao-feng, SHEN Yu-juan. Research progress on liver fibrosis caused by Echinococcus infection [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(5): 656-660. |
[4] | FENG Jia-xin, GONG Yan-feng, LUO Zhuo-wei, WANG Wei, CAO Chun-li, XU Jing, LI Shi-zhu. Scientific basis of strategies for schistosomiasis control and prospect of the 14th Five-Year Plan in China [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(4): 428-435. |
[5] | CHEN Bing, ZHANG Guo-li, ZHANG Gao-hong. Research progress on clinical trials of schistosomiasis vaccine candidates [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(4): 511-515. |
[6] | GAO Yuan, HU Yuan, CAO Jian-ping. Research progress on the role of immune cells in liver fibrosis due to schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2022, 40(1): 88-93. |
[7] | GUO Su-ying, ZHU Hong-qing, CAO Chun-li, DENG Wang-ping, BAO Zi-ping, JIA Tie-wu, LI Yin-long, LV Chao, QIN Zhi-qiang, ZHANG Li-juan, FENG Ting, YANG Fan, LV Shan, XU Jing, LI Shi-zhu. Risk assessment of schistosomiasis transmission along the middle and lower reaches of Yangtze River after flooding in 2020 [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(6): 753-758. |
[8] | SHI Liang, XIONG Chun-rong, LIU Mao-mao, WEI Xiu-shen, ZHANG Jian-feng, WANG Xin-yao, WANG Tao, HANG De-rong, YANG Hai-tao, YANG Kun. Evaluation of efficacy of visual intelligent recognition model for Oncomelania hupensis based on deep learning technology [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(6): 764-770. |
[9] | LI Bo, ZHANG Cong, SHAN Xiao-wei, YI Jia, TU Zhen, HE Hui, TANG Li, ZHU Hong, LIU Jian-bing. Evaluation of the pathogen detection capacity in standardized schistosomiasis laboratories in Hubei Province [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 572-576. |
[10] | WU Jia-li, LI Bo, LIU Si, TU Zu-wu, TANG Li, TU Zhen, ZHOU Xiao-rong, SUN Ling-cong, XIAO Ying, ZHU Hong. Assessment of transmission risk of human schistosomiasis japonica based on human population antibody level in Hubei Province [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 578-584. |
[11] | HU Fei, GAO Zhu-lu, YUAN Min, LI Zhao-jun, LI Yi-feng, LIU Yue-min, LI Jian-ying, XIE Shu-ying, WEN Yu-song, LIN Dan-dan. Changing trends of schistosome infection and liver fibrosis among residents in the Poyang Lake region [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 629-636. |
[12] | LIU Rong, ZHANG Jian-feng, YAN Xiao-lan, WEN Li-yong. Comparative study of SF-36 and EQ-5D-5L in evaluating quality of life for patients with advanced schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(5): 639-645. |
[13] | LIU Rong, WEN Li-yong. New progress in basic and clinical research of advanced schistosomiasis [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(4): 429-436. |
[14] | HONG Zhong, WU Ling-ling, WANG Li-ping, XU Jing. Progress and challenges on global schistosomiasis control [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(4): 514-519. |
[15] | WANG Li-ping, QIN Zhi-qiang, LV Shan, LI Shi-zhu, ZHOU Xiao-nong, XU Jing. Prevalence and challenges in elimination of schistosomiasis mekongi [J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020, 38(6): 758-763. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||